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Abstract
Throughout the United States, air pollution correlates with adverse health outcomes, and 
cardiovascular disease incidence is commonly increased following environmental exposure. In 
areas surrounding active mountaintop removal mines (MTM), a further increase in cardiovascular 
morbidity is observed and may be attributed in part to particulate matter (PM) released from the 
mine. The mitochondrion has been shown to be central in the etiology of many cardiovascular 
diseases, yet its roles in PM-related cardiovascular effects are not realized. In this study, we 
sought to elucidate the cardiac processes that are disrupted following exposure to mountaintop 
removal mining particulate matter (PMMTM). To address this question, we exposed male Sprague-
Dawley rats to PMMTM, collected within one mile of an active MTM site, using intratracheal 
instillation. Twenty-four hours following exposure, we evaluated cardiac function, apoptotic 
indices, and mitochondrial function. PMMTM exposure elicited a significant decrease in ejection 
fraction and fractional shortening compared with controls. Investigation into the cellular impacts 
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of PMMTM exposure identified a significant increase in mitochondrial-induced apoptotic 
signaling, as reflected by an increase in TUNEL-positive nuclei and increased caspase-3 and -9 
activities. Finally, a significant increase in mitochondrial transition pore opening leading to 
decreased mitochondrial function was identified following exposure. In conclusion, our data 
suggest that pulmonary exposure to PMMTM increases cardiac mitochondrial-associated apoptotic 
signaling and decreases mitochondrial function concomitant with decreased cardiac function. 
These results suggest that increased cardiovascular disease incidence in populations surrounding 
MTM mines may be associated with increased cardiac cell apoptotic signaling and decreased 
mitochondrial function.
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NEW & NOTEWORTHY
We describe for the first time cardiac and mitochondrial dysfunction following an 
acute pulmonary exposure to a unique particulate matter, which arises from the 
process of mountain-top removal, common in surface mining operations. Our 
findings suggest enhanced cardiac risk for populations living in close proximity to 
mountaintop mining operations.
The world health organization estimates that 3.7 million premature deaths a year are 
attributed to ambient air pollution (75). While the lungs are the primary tissue impacted by 
air pollution exposure, more than 80% of these deaths are due to cardiovascular disease (75). 
Throughout the United States, decreased air quality correlates with adverse health effects, 
including negative cardiovascular end points (57, 60, 61, 64). Although chronic exposure to 
air pollution is the 13th leading cause of worldwide mortality (76), short-term particulate 
matter (PM) exposure has also been suggested to contribute to tens of thousands of deaths 
within the United States (60, 70c). Air pollution is a complex mixture of many compounds, 
including PM, and epidemiological data link PM concentration to adverse cardiovascular 
effects (84). PM itself is a heterogeneous mixture of particles that vary in size, chemical 
composition, and origin; nevertheless, persistent PM formation creates a near-universal 
inhalation exposure. Although PM exposure is widespread, the makeup of this material 
varies considerably based on origin and geographical region (70c). These differing 
compositions may play a distinct role in adverse cardiovascular end points associated with a 
specific geographic locale (22).
The United States is among the most active coal-producing countries in the world (28), and 
coal mining is projected to increase over the next 25 years (70a). The Appalachian region, 
which extends from southern New York to Mississippi and Georgia following the 
Appalachian Mountains, contains more than eight hundred active coal mines, accounting for 
30% of US mining activity (70b). Due to its inherent less labor-intensive methods, surface 
mining is beginning to outnumber traditional underground mining two to one (70b). One 
popular, less labor-intensive method of surface mining is mountaintop removal mining 
(MTM), which utilizes explosives to remove the mountaintop, freeing underlying coal 
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seams, allowing easier extraction. Economically and ecologically, the technique is 
controversial, but few studies have begun to investigate the human health impacts in areas 
surrounding MTM sites. The PM generated by the MTM process contains toxicants that are 
environmentally biopersistent (55), suggesting potential for negative health effects.
Although the goal of industrial processes is to abate dust generation, fugitive dust from 
explosive treatment as well as combustion particles from heavy equipment create a unique 
PM (PMMTM). Epidemiologically, health effects of coal mining have been outlined (81, 88), 
but, until recently, no comparisons had been drawn between areas surrounding underground 
and MTM sites. Studies have reported that PMMTM causes an increase in chronic 
cardiovascular disease mortality rates among populations in close proximity to active MTM 
sites (28). However, the mechanisms underlying this observation are poorly understood. We 
have previously reported that acute pulmonary exposure to PMMTM in rodents is linked to 
microvascular dysfunction in extrapulmonary tissue (36). However, studies on cardiac tissue 
have not been undertaken.
The mitochondrion has been implicated in the etiology of many cardiovascular diseases 
because of the crucial roles it plays within the cardiomyocyte. Among the central roles for 
the mitochondrion are the production of ATP requisite for cardiac contraction and relaxation 
as well as its contribution to the signals initiating cellular apoptosis. In vivo and in vitro 
analyses have revealed an increase in apoptosis in numerous tissues following PM exposure 
(2, 16, 85, 86). Two pathways reported to activate the apoptotic cascade include the extrinsic 
pathway via caspase-8 and the intrinsic pathway involving the mitochondrion. In the 
intrinsic pathway, opening of the mitochondrial permeability transition pore (mPTP) allows 
uncoupling of the electron transport chain, leading to mitochondrial dysfunction and 
formation of the apoptosome (31). In vitro evidence suggests that both extrinsic and intrinsic 
pathways are activated following PM exposure (20). Nevertheless, it is unclear whether 
acute PMMTM exposure is associated with mitochondrial dysfunction or enhanced initiation 
of the apoptotic cascade.
The goals of the present study were to determine whether acute PMMTM exposure is 
associated with cardiac and mitochondrial dysfunction and to elucidate whether these effects 
were associated with mitochondrial-associated apoptosis initiation with an emphasis on the 
cardiomyocyte. Our results suggest that acute PMMTM exposure is associated with an 
increase in mitochondrial-driven apoptotic signaling, which may contribute to cardiac and 
mitochondrial dysfunction. These findings lend insight into the potential mechanisms 
underlying acute PMMTM exposure effects in the heart.
MATERIALS AND METHODS
Experimental animals
The animal experiments in this study were approved by the West Virginia University 
Animal Care and Use Committee and conformed to the most current National Institutes of 
Health (NIH) Guidelines for the Care and Use of Laboratory Animals manual. Male 
Sprague-Dawley rats were housed in the West Virginia University Health Sciences Center 
animal facility. Rats were given access to a rodent diet and water ad libitum.
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PM was collected on 35-mm, 5-μm pore size polytetrafluoroethylene fiber-backed filters 
(Whatman, Springfield Mill, UK) for 2–4 wk at two sites within 1 mile of an active MTM 
site. Particle storage and extraction from the filters following collection are consistent with 
previous reports (24). Briefly, filters were stored at room temperature (20–25°C) and 
ambient humidity (10–30%) before extraction. PM extraction was accomplished by gentle 
agitation in ultrapure water for 96 h. Particle suspension aliquots were then dried in a 
Speedvac (Savant, Midland, MI), and total particle weight was determined using a 
microbalance (Metler-Toledo, Columbus, OH).
Intratracheal instillation
Intratracheal instillation was performed according to the method of Brain et al. (4) as 
previously described (36, 45, 46, 49, 50). Briefly, following anesthesia with isoflurane, a 
ball needle attached to a 1-ml tuberculin syringe was inserted under the glottis into the 
trachea, and 300 μl of either vehicle (5% fetal bovine serum in phosphate-buffered saline) or 
vehicle with 300 μg of PMMTM was instilled directly into the trachea. We have previously 
shown that this dose of PMMTM partially impaired endothelium-dependent microvascular 
dysfunction (36). The PM characterization and resuspension were carried out as described 
previously (36).
Cardiac contractile function
Twenty-four hours following exposure, echocardiography was utilized to assess cardiac 
contractile function. For echocardiographic assessment, each rat was anesthetized in a 
knockdown box with inhalant isoflurane at 2.5% in 100% oxygen. Following anesthesia, 
ultrasound images were acquired with a 25-MHz linear array transducer using the Vevo2100 
Imaging System (Visual Sonics, Toronto, Ontario, Canada). M-mode images were acquired 
by placing the transducer to the left of the sternum and obtaining an image at the mid-
papillary muscle level. A gate was placed through the center of the short-axis B-mode image 
to obtain M-mode recordings of contractile parameters of the myocardium. Images were 
acquired using the highest possible frame rate (233–401 frames/s). Measurements obtained 
from left ventricular M-mode images included end-diastolic and end-systolic diameters and 
volumes, fractional shortening, ejection fraction, stroke volume, and cardiac output. All M-
mode image measurements were calculated over three consecutive cardiac cycles and 
averaged.
Tissue preparation and compartment isolation
After cardiac contractile measurements were performed, rats were euthanized and hearts 
excised. Atrial and right ventricular tissues were removed, and left ventricular tissue was 
utilized for the studies. Cytosolic isolation was performed as previously described (77). 
Subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM) subpopulations 
were isolated as previously described following the methods of Palmer et al. (54) with minor 
modifications by our laboratory (4, 5, 14, 15, 17, 18, 70, 77). Mitochondrial pellets were 
resuspended in KME buffer (100 mM KCl, 50 mM MOPS, and 0.5 mM EGTA pH 7.4) and 
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utilized for all analyses. Protein concentrations were determined by the Bradford method 
using bovine serum albumin as a standard (8).
TUNEL staining
Terminal dUTP nick-end labeling (TUNEL) was performed to detect apoptotic nuclei in 
tissue cross sections, as previously described (32, 74). Briefly, frozen tissue (10 μm thick) 
cross sections of left ventricle were mounted on charged microscope slides (Fisher 
Scientific, Pittsburgh, PA), air dried, and incubated overnight at 4°C with mouse anti-heavy 
chain cardiac myosin antibody (no. ab50967; Abcam, Cambridge, MA). Sections were then 
incubated with goat anti-mouse Cy5-conjugated secondary antibody (no. ab6563; Abcam), 
fixed with 4% paraformaldehyde, and permeabilized with 0.1% Triton X-100 in PBS at 4°C. 
Sections were incubated with the TUNEL reaction mixture (Roche Diagnostics, 
Indianapolis, IN) in a humidified chamber in the dark. The exclusion of the TdT enzyme in 
the TUNEL reaction mixture on one of the tissue sections on each slide was included as a 
negative control (Fig. 1A). Treatment of one tissue section on each slide with DNase I (Life 
Technologies, Carlsbad, CA) was included as a positive control (Fig. 1B). Sections were 
mounted and stained with a mounting medium containing DAPI (Vectashield; Vector 
Laboratories, Burlingame, CA) to observe nuclei. Slides were then visualized under a Zeiss 
Axio Imager Z2 (Carl Zeiss Microimaging, Thornwood, NY). The number of TUNEL- and 
DAPI-positive nuclei were counted, and the data were expressed as an apoptotic index, 
which was calculated as the percentage of TUNEL-positive nuclei relative to the total 
myonuclei (i.e., DAPI-positive nuclei) pool. The apoptotic index was determined from four 
nonoverlapping regions of each tissue cross section.
Histone ELISA
Cytoplasmic histone-associated DNA fragments related to apoptosis were quantified 
utilizing the Cell Death Detection ELISAPLUS kit (no. 11774425001; Roche Diagnostics). 
This photometric enzyme immunoassay, which is used for the quantitative determination of 
mono- and oligonucleosomes after cell death, was carried out per the manufacturer’s 
instructions.
Western blotting
SDS-PAGE was run on 4–12% gradient gels, as previously described (4, 5, 17, 18, 43, 70, 
77). Relative amounts of activated caspase-3, -9, and -8 were determined using specific 
antibodies: anti-caspase-3 rabbit antibody (no. 3016-100; Biovision, Milpitas, CA), anti-
caspase-9 rabbit antibody (no. 9665; Cell Signaling Technology, Danvers, MA), and anti-
caspase-8 goat antibody (no. Sc6134; Santa Cruz Biotechnology, Dallas, TX). Relative 
amounts of B-cell CLL/lymphoma 2 (Bcl-2), Bcl-2-associated X protein (Bax), apoptosis 
protease-activating factor 1 (APAF-1), and cytochrome c were determined using specific 
antibodies: anti-Bcl-2 mouse antibody (no. sc-7382; Santa Cruz Biotechnology), anti-Bax 
rabbit antibody (no. ab32503; Abcam), anti-APAF-1 rabbit antibody (no. ab2000; Abcam), 
and anti-cytochrome c rabbit antibody (no. 4272; Cell Signaling Technology). Relative 
amounts of mitochondrial permeability transition pore constituents, adenine nucleotide 
translocase (ANT), voltage-dependent anion channel (VDAC), and cyclophilin D (CypD) 
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were determined using specific antibodies: anti-ANT goat antibody (no. sc-9300; Santa Cruz 
Biotechnology), anti-VDAC rabbit antibody (no. 4866; Cell Signaling Technology), and 
anti-CypD rabbit antibody (no. PA1-028; Affinity Bioreagents, Golden, CO). The secondary 
antibodies used included: goat anti-mouse IgG horseradish peroxidase (HRP) conjugate (no. 
31430; Pierce Biotechnology, Rockford, IL), goat anti-rabbit IgG HRP conjugate (no. 
10004301; Cayman Chemical, Ann Arbor, MI), and donkey anti-goat IgG HRP conjugate 
(no. sc-2020; Santa Cruz Biotechnology). Pierce Enhanced Chemiluminescence Western 
Blotting substrate (Pierce) was used to detect signal following the manufacturer’s 
instructions. A G:Box Bioimaging system (Syngene, Frederick, MD) was used to assess 
autoradiographic signals. Data were captured using GeneSnap/GeneTools software 
(Syngene), and densitometry was analyzed using Image J software (National Institutes of 
Health, Bethesda, MD). Controls for protein loading included anti-GAPDH mouse antibody 
(no. ab8245; Abcam) for cytosolic analyses and anti-COXIV rabbit antibody for 
mitochondrial analyses (no. ab16056; Abcam).
Caspase activation
Caspase activities were assessed as previously described (77, 78). Briefly, whole left 
ventricular tissue was homogenized in the absence of a protease inhibitor cocktail to enable 
assessment of caspase-3, caspase-8, and caspase-9 activities. All of the activities were 
measured in a caspase activation buffer containing 4.8 mmol PIPES, 0.1 mmol EDTA, and 
10% glycerol. For each enzyme activity assay, specific substrates were added: caspase-3, 
Ac-DEVD-AFC (Alexis Biochemicals, San Diego, CA); caspase-8, Ac-IETD-AMC (Alexis 
Biochemicals); and caspase-9, Ac-LEHD-AFC (Alexis Biochemicals). An aliquot (100 μg) 
of each sample was loaded with the appropriate substrate and allowed to incubate for 2 h in 
the dark at 37°C. Samples were read fluorometrically using a Flexstation 3 plate reader 
(Molecular Devices, Sunnyvale, CA). Fluorometric measurements were performed at 
excitation/emission wavelengths of 400 nm/505 nm and expressed in relation to protein 
content.
Immunoprecipitation
Isolated mitochondrial protein was incubated overnight with a primary anti-Bax rabbit 
antibody (no. ab32503; Abcam). Dynabeads Protein G superparamagnetic beads (product 
No. 10003D; ThermoFisher Scientific, Waltham, MA) were then added to the sample 
mixture and allowed to incubate for 1 h. After the beads were washed, the protein was 
eluted, heated, and run through SDS-PAGE as described above. Following SDS-PAGE, 
immunoblotting for relative amounts of Bcl-2 and Bax were accomplished as described 
above.
mPTP opening
mPTP opening was performed as previously described by measuring mitochondrial swelling 
spectrophotometrically (540 nm) and observing the decrease in light scattering (1, 77). 
Treatment of freshly isolated mitochondrial subpopulations with 100 μM tert-butyl 
hydroperoxide (t-BuOOH), 400 μM Ca2+, and 10 mM succinate induced swelling and was 
followed using a Flexstation 3 plate reader (Molecular Devices). As an assay control, 1 μM 
cyclosporin A, a specific mPTP inhibitor, was added to the reaction mixture.
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Mitochondria size and internal complexity
Size and complexity of the mitochondria were analyzed as previously described (18, 19) 
using a FACS Calibur flow cytometer equipped with a 15-MW 488-nm argon laser and 633-
nm red diode laser (Becton and Dickinson, San Jose, CA). Each individual parameter 
(gating, size, and complexity) was measured using specific detectors and light sources (laser, 
photomultiplier tube). The dye MitoTracker Deep Red (no. M22426, Life Technologies), 
which passively diffuses into intact mitochondria, was used to selectively stain for 
mitochondria. Freshly isolated mitochondrial subpopulations were incubated with the dye, 
and 20,000 gated events were analyzed per sample. Gating parameters were established, and 
the forward scatter detector (FSC; 488 nm argon laser and diode detector) and side scatter 
detector (SSC; photomultiplier tube and 90° collection lens) were represented in FSC and 
SSC density plots. To represent size, FSC (logarithmic scale) geometric mean (arbitrary 
units) was used; to represent complexity, SSC (logarithmic scale) geometric mean (arbitrary 
units) was observed. All flow cytometry data collection was supervised by the West Virginia 
University Flow Cytometry Core Facility.
Electron microscopy
A section of left ventricle was cut and fixed in 3% glutaraldehyde in sodium cacodylate 
buffer for electron microscopy images. Briefly, sections were postfixed by incubation with a 
1.0%/0.8% osmium tetroxide/potassium ferricyanide mixture (Electron Microscopy Science, 
Hatfield, PA), dehydrated through a graded series of ethanol solutions and acetone, and then 
embedded in Epon resin (SPI Supplies, Westchester, PA). Ultrathin sections (95 nm) were 
cut from the resulting blocks with a Leica EM UC7 ultramicrotome (Leica Biosystems, 
Buffalo Grove, IL) and then captured on 200 mesh copper electron microscopy grids. The 
sections were observed at 80 kV with a JEOL JEM-1010 electron microscope (JEOL USA, 
Peabody, MA) connected to an AMT XR611S-B (ORCA HR) digital camera driven by 
Image Capture Engine software (AMT, Woburn, MA) for image acquisition and analysis. 
All electron microscopy imaging was performed in conjunction with the West Virginia 
University Pathology Electron Microscopy Core Facility.
Mitochondrial respiration
State 3 and state 4 respiration rates were analyzed in freshly isolated mitochondrial 
subpopulations, as previously described (12, 13) with modifications by our laboratory (15, 
17, 19, 70). Briefly, isolated mitochondrial subpopulations were resuspended in KME 
buffer, and protein content was determined by the Bradford method (8). Mitochondrial 
protein was added to respiration buffer (80 mM KCl, 50 mM MOPS, 1 mmol/l EGTA, 5 
mmol/l KH2PO4, and 1 mg/ml BSA) and placed into a Gilson Chamber (Gilson, Middleton, 
WI) attached to a Yellow Springs Instruments 5300 biological oxygen monitor (Yellow 
Springs Instruments, Yellow Springs, OH). Maximal complex I-mediated respiration was 
initiated by the addition of glutamate (5 mM) and malate (5 mM). Data for state 3 (250 mM 
ADP) and state 4 (ADP limited) respiration were expressed as nanomoles of oxygen 
consumed per minute per milligram of protein.
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Means and SE were calculated for all data sets. A Student’s t-test was employed to analyze 
differences between treatment groups using GraphPad Prism 5 software (GraphPad 
Software, La Jolla, CA). P < 0.05 was considered significant.
RESULTS
Cardiovascular function following PMMTM exposure
Although overt cardiac dysfunction is not commonly an end point of PM exposure, acute 
PM exposure has been linked to cardiac stress (60); thus we began our investigation by 
evaluating cardiac function using echocardiography. Twenty-four hours following acute 
PMMTM exposure, a significant increase in both end-systolic volume and diameter was 
observed, but no significant changes in end-diastolic parameters were noted (Table 1). Acute 
PMMTM exposure led to decreases in ejection fraction and fractional shortening compared 
with control animals (Table 1).
Apoptotic signaling following PMMTM exposure
Cardiac contractile dysfunction is associated with cell death; therefore, we determined 
whether acute PMMTM exposure triggered apoptotic signaling in the heart. Cardiomyocytes 
from PMMTM-exposed animals (Fig. 1D) displayed an increase in TUNEL-positive nuclei, 
which fluorescently labels DNA nicks, compared with control animals (Fig. 1C), suggestive 
of an increase in damage downstream of apoptotic signaling. Summary data for TUNEL-
positive nuclei in both control and PMMTM-exposed hearts can be seen in Fig. 1E. To 
confirm apoptotic initiation, we determined cytosolic histone content following PMMTM 
exposure and found that exposure significantly increased histone concentrations (Fig. 1F).
Downstream signals of the apoptotic pathway may be differentially activated depending on 
the pathway of apoptosis initiated by a given stressor. Among the signaling pathways 
responsible for the apoptosis cascade are those driven by the extrinsic mechanism 
(caspase-8) as well as those driven by the intrinsic mechanism via the mitochondrion 
(caspase-9 and caspase-3) (56). No increase in the activity of caspase-8 was observed, 
suggesting that the extracellular pathway of apoptotic induction is not activated following 
PMMTM exposure (Fig. 2A). In contrast, PMMTM exposure enhanced the activity of both 
caspase-9 (Fig. 2B) and caspase-3 (Fig. 2C). These findings were supported by 
immunoblotting analysis of relative active caspase concentrations, which suggested an 
increase in caspase-3 (Fig. 2F) and caspase-9 (Fig. 2E) relative to control with no change in 
caspase-8 (Fig. 2D) following PMMTM exposure. These findings indicate that the 
mitochondrion may play a role in the induction of cardiac apoptotic signals following acute 
PMMTM exposure.
Apoptosome formation requires a number of molecular constituents, including APAF-1 and 
cytochrome c (83). Western blot analyses on the cytosolic fraction of left ventricular tissue 
from acute PMMTM-exposed animals revealed a significant increase in APAF-1 content 
compared with control animals (Fig. 3A). Concurrently, there was an increase in the 
cytosolic cytochrome c content following acute PMMTM exposure (Fig. 3B), confirming a 
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role of the mitochondrion in cardiac cell apoptotic signaling. Evaluation of mitochondrial 
cytochrome c content following acute PMMTM exposure revealed a significant decrease in 
the SSM subpopulation (Fig. 3C) without impact on the IFM subpopulation (Fig. 3D). 
Taken together, these findings suggest an enhanced release of cytochrome c from cardiac 
SSM following acute PMMTM exposure, which leads to apoptosome formation and 
mitochondrially driven apoptotic initiation.
To complement our apoptotic signaling analyses, we examined additional nonspecific 
cellular markers of apoptosis. BH3 proteins are a class of both pro- and antiapoptotic 
proteins found within the cytosol that are differentially expressed following cellular damage 
and act to either prevent or propagate apoptosis. Examination of the antiapoptotic protein 
Bcl-2 revealed a significant decrease following acute PMMTM exposure (Fig. 4A). In 
contrast, no significant difference in the relative content of its antagonistic proapoptotic Bax 
protein was noted (Fig. 4B). The decrease in Bcl-2 led to a significant increase in the 
Bax:Bcl-2 ratio (Fig. 4C), suggesting a proapoptotic cellular environment. Bcl-2 and Bax are 
able to counteract each other’s actions by forming dimers, either hetero or homo, to 
complete their anti- or proapoptotic activities. Therefore, it is the dimerization of these 
proteins that suggests mitochondrial apoptotic signaling. Immunoblotting for Bax following 
immunoprecipitation with an anti-Bax antibody indicated that there is an increase in 
Bax:Bax dimerization following exposure (Fig. 4E). When investigating the Bax:Bcl-2 
dimerization, we observed no significant difference in the levels of Bcl-2 following 
pulldown with Bax in the animals exposed to PMMTM (Fig. 4D). These results led us to 
observe an increase in the proapoptotic Bax:Bax homodimerization, compared with the 
antiapoptotic Bax:Bcl-2 heterodimerization following exposure to PMMTM (Fig. 4F). These 
data further suggest that cardiac mitochondrial apoptotic signaling is increased following 
pulmonary PMMTM exposure.
mPTP opening propensity
Mitochondrial-initiated apoptotic signaling is associated with the opening of the mPTP (42). 
We investigated mPTP opening propensity by inducing mitochondrial swelling using an 
exogenous oxidant (t-BuOOH). When the mPTP is open, the space that is occupied by the 
mitochondrial matrix is increased, and the time to Vmax represents the rate of pore opening. 
Relative absorbance plots are presented for mPTP opening in SSM (Fig. 5A) and IFM (Fig. 
5C). Each plot includes control, acute PMMTM exposure, and an internal control consisting 
of cyclosporin A treatment, which limits mPTP opening. In general, IFM displayed greater 
times to Vmax compared with SSM (Fig. 5, B and D; open bars), which is in agreement with 
other reports (1, 77). The time to Vmax was significantly decreased in the SSM 
subpopulation following acute PMMTM exposure (Fig. 5B). In contrast, mPTP opening 
propensity was not significantly altered in IFM following acute PMMTM exposure (Fig. 5D). 
These results suggest that mPTP opening propensity is enhanced following acute PMMTM 
exposure only in the SSM subpopulation, and, as a result, SSM are more susceptible to 
oxidant-induced apoptotic stimuli.
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Because of the observed enhanced mPTP opening propensity, we determined whether 
putative constituents of the pore were affected following acute PMMTM exposure. 
Specifically, we assessed the contents of ANT, VDAC, and CypD in both mitochondrial 
subpopulations. Acute PMMTM exposure induced no change in VDAC (Fig. 6, A and B) or 
ANT (Fig. 6, C and D) in either mitochondrial subpopulation. In contrast, an increase in the 
levels of the regulatory subunit CypD was noted in the SSM (Fig. 6E) following acute 
PMMTM exposure with no significant change in the IFM (Fig. 6F). These results indicate an 
increase in the CypD content in the SSM following acute PMMTM exposure, which may 
contribute to the increased pore opening propensity.
Mitochondrial subpopulation morphology
mPTP opening is associated with morphological changes to the mitochondrion (31). To 
assess the impact of acute PMMTM exposure on mitochondrial morphology, we utilized flow 
cytometry to determine relative size and internal complexity, as previously described (15, 
17–19, 77). Using this approach, we have reported that SSM tend to be larger and more 
complex than IFM (15, 17, 18, 77), and data from the present study are in agreement with 
these reports (Fig. 7, A and B; open bars). In both the SSM and IFM, there were significant 
decreases in forward scatter (size) (Fig. 7A) and side scatter (internal complexity) (Fig. 7B) 
following acute PMMTM exposure. The results were surprising and indicate that both the 
SSM and IFM were smaller and had decreased internal complexity following acute PMMTM 
exposure, suggesting that mitochondrial morphology may be affected in both 
subpopulations. Qualitative assessment of electron micrographs of left ventricular tissues 
from control (Fig. 7C) and exposed animals (Fig. 7D) indicated that mitochondria were 
smaller following exposure, further supporting the data presented in Fig. 7A.
Mitochondrial respiratory function
Mitochondrial dysfunction is frequently concomitant with increased apoptotic signaling; 
therefore, we determined the respiratory capacity following acute PMMTM exposure through 
evaluation of state 3 and state 4 respiration rates. Representative respiratory plots for the 
SSM and IFM can be seen in Fig. 8, A and C, respectively. We observed a significant 
decrease in state 3 respiration (active) following acute PMMTM exposure in both the SSM 
(Fig. 8B) and IFM (Fig. 8D). No significant changes in the state 4 respiration, or resting 
respiration rate, in either subpopulation were noted following acute PMMTM exposure. 
These findings suggest that acute PMMTM exposure elicits disruption to respiratory capacity 
in both mitochondrial subpopulations.
DISCUSSION
Acute and chronic PM inhalation exposure contributes to and exacerbates cardiovascular 
disease and mortality (21, 70c). Within the Appalachian region, MTM activity creates a 
unique exposure, which, combined with mining longevity, may contribute to increased 
mortality from chronic diseases. Although epidemiological data are convincing, the 
underlying mechanisms responsible for increased morbidity following PMMTM exposure are 
relatively unexplored. Utilizing an acute pulmonary exposure model, we investigated the 
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effects of acute PMMTM exposure on cardiovascular function and metabolic disposition. Our 
data reveal decreases in cardiac pump function concomitant with increased mitochondria-
driven apoptotic signaling and decreased mitochondrial respiratory function.
Particle composition varies by region in the US, and this variability may underlie health 
disparities for a given geographical region. Characterization of the particles utilized in this 
study indicated elements and sizes similar to those resulting from the combination of 
mineralogical materials, as well as engine exhaust emission (36). MTM utilizes blasting, 
crushing, and grinding of materials, which are commonly accomplished and transported by 
heavy machinery burning off-road diesel fuel. Validation of the PM was accomplished in 
another study highlighting natural and exhaust emissions, primarily geological, surrounding 
opencast mines similar to MTM (35). The dominant size range was ultrafine to 0.2 μm, 
based on mass measurement, and the principal particle composition was likely crustal with a 
bulk of particles appearing anthropogenic in origin (79). Previous elemental analyses 
support the notion that the bulk of the particle was from crustal sources (36). Further 
confirmation of composition was obtained by comparing PM from MTM sites and non-
MTM sites and observing crustal material enriched within the surface mining samples by 
factors greater than 10 (39). These authors concluded that the PM was similar to coal dust 
and crustal material with the presence of local combustion sources. The authors also 
suggested that, because of the nature of the landscape surrounding the mines (steep valleys 
with lower wind speeds and less vertical mixing), there would be less PM transport, creating 
an increase in the inhaled deposited lung deposition and greater health effects (40). Whether 
or not these elements and observations are consistent with our observations remain to be 
determined in future experiments.
Although extrapulmonary toxicological effects are well documented, the mechanisms of 
toxicity are still under considerable debate. Three potential hypotheses have been advanced 
to explain extrapulmonary effects: 1) a systemic inflammatory response that is initiated in 
the lung, 2) translocation of the PM to extrapulmonary tissue, and 3) neural effects (9, 23). 
Studies in both murine and human models have identified proinflammatory markers in the 
circulation of exposed subjects, providing evidence that a pulmonary insult may stimulate a 
systemic inflammatory response (7, 33, 58, 62, 63, 68, 71, 73), which may contribute to 
downstream cardiovascular effects (47, 51). Data also exist suggesting PM translocation 
from the lung to the affected tissues (26, 38, 52, 53, 67). Pulmonary exposure damages lung 
epithelium, increasing permeability and enabling PM penetration from the gaseous exchange 
region, leading to escape into the circulation with subsequent impact on extrapulmonary 
tissues (48, 65). Finally, PM exposure may interfere with neuronal signaling and cardiac 
autonomic dysfunction following exposure (10, 11, 59). Although the hypotheses are 
scientifically independent, the mechanisms are not mutually exclusive and may overlap, 
propagating activation of additional mechanisms. Although these mechanisms have not been 
explored following PMMTM exposure, acute exposure to other PM has implicated a systemic 
inflammatory response (44). This question is not experimentally addressed in this study, but 
it is a crucial concept in fully understanding the interaction between pulmonary damage and 
extrapulmonary toxicity.
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Acute PM exposure has been shown to contribute to cardiovascular morbidity and mortality. 
To investigate the cardiac contractile response following acute PMMTM exposure, we 
utilized echocardiography and observed decreases in ejection fraction and fractional 
shortening, which were associated with increases in both end-systolic volume and diameter. 
One study investigating the effect of diesel exhaust particle inhalation exposure on cardiac 
function reported similar decreases in fractional shortening, yet this functional decrease was 
due to diastolic effects with an increase in end-diastolic diameter (82). Similarly, decreased 
fractional shortening following PM exposure was identified in senescent mice (69). Prenatal 
PM exposure reduced fractional shortening (30) and a chronic model of PM exposure 
decreased ejection fraction (80), demonstrating the detrimental role PM exposure plays in 
the progression of heart disease. Following PM exposure, overt cardiac dysfunction is not 
commonly observed in humans; however, cardiac remodeling occurs, indicating cardiac 
stress (72). Our results suggest conditions of early cardiac stress and alteration which, if 
maintained, may contribute to the onset and progression of cardiovascular disease.
To identify the cellular mechanisms contributing to cardiac contractile dysfunction 
following PM exposure, we focused on apoptotic signaling, the role of which has not been 
widely investigated in PM toxicology. Research into histological changes following oil 
combustion-derived, fugitive emission PM exposure indicated no change in cardiac cell 
apoptosis in a chronic model (37). It is unclear why these results differ from those in the 
present study, but it may be a function of differences in particle composition or a transient 
increased response, which ultimately triggers compensatory mechanisms to attenuate cell 
death. In addition, the activation of caspase cascades is a critical step in the induction of 
apoptosis, and our study identified increased cardiac caspase activity following PMMTM 
exposure. Activation of both caspase-8 and -9 in the lung following PM exposure has been 
reported (29). In the present study, activation of caspase-3 and -9 suggested a mitochondrial 
role in apoptotic signaling associated with PMMTM exposure. Additional studies are needed 
to determine whether these effects are specific to the cardiomyocyte. Interestingly, 
differences in absolute changes following PMMTM exposure were observed between the 
TUNEL staining and the caspase activity analyses, in which TUNEL staining revealed a 
greater overall change compared with caspase activation. It should be pointed out that the 
TUNEL measurements were performed by staining specifically for cardiomyocytes, whereas 
the caspase activities were conducted on whole heart tissue, which may have diluted the 
overall absolute change. Furthermore, TUNEL analyses tend to be more sensitive in terms of 
absolute detection resolution.
The mPTP is considered a key nodal point in mediating cardiac dysfunction and cellular 
death. Pore opening enables release of proapoptotic proteins, including cytochrome c. Our 
study revealed increased propensity for mPTP opening specifically in the SSM following 
PMMTM exposure. Although the constituents of the mPTP have been debated, CypD has 
been regarded as the regulatory subunit of the pore and necessary for pore opening (3). Our 
study revealed no difference in the content of putative pore constituents VDAC and ANT, 
yet we observed a significant increase in CypD content in the SSM following PMMTM 
exposure. These data support a hypothesis of increased pore opening propensity specific for 
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the SSM following PMMTM exposure. Differential subpopulation responses to apoptotic 
stimuli are consistent with other pathological models (1, 77).
Many studies indicate that mitochondrial spatial location may be associated with a specific 
response to pathological stimuli (34). Two spatially distinct mitochondrial subpopulations 
have been noted in the myocyte: SSM, which reside below the cell membrane, and IFM, 
which exist between the myofibrils. In the present study, SSM displayed increased apoptotic 
propensity following PMMTM exposure. In contrast, both mitochondrial subpopulations 
displayed decreased active respiration rates after PMMTM exposure. These findings indicate 
that, following PMMTM exposure, there could potentially be a spatial component to 
metabolic insult. Furthermore, these data suggest that SSM are impacted to a greater extent 
by PMMTM exposure, and, on the basis of their spatial position, we speculate that the 
primary source of cellular stress comes from outside the sarcolemma. SSM act as a 
protective barrier to the cell interior, maintaining permissive oxygen levels and the resulting 
cellular milieu (41, 66). We theorize that the impact to SSM supports the hypothesis that a 
pulmonary particle insult stimulates a systemic response, such as inflammation, which 
affects the cell at its periphery. It has been indicated that mitochondrial subpopulations can 
communicate across the cell, providing a platform for mitochondrial synchronization (87). 
The degree of interaction between these two subpopulations is of debate, but one hypothesis 
indicates that the innermost SSM and the outermost IFM are connected through 
mitochondrial filaments enabling metabolic coupling (66). If such a scenario were to exist, 
one could hypothesize that a significant insult at the SSM could stimulate dysfunction to the 
IFM.
In this study, we chose to use an acute exposure to PMMTM using intratracheal instillation at 
a dose that would be similar to an accumulated dose over 1.7 yr. This dose was based on 
ambient recorded concentrations of 8.3 μg/m3 and a minute ventilation of 200 ml/min with 
an estimated deposition fraction of 0.2 and was chosen because previous effects have been 
observed (36). Given that our model resembles a young, healthy population, our findings 
may be of even greater significance to older populations and populations with preexisting 
conditions. It should be noted that other methods of pulmonary exposure (e.g., inhalation), 
as well as a chronic model, may be more translationally relevant. This may be particularly 
applicable for heart failure, which can be influenced by mitochondrial dysfunction through 
bioenergetic deficit and myocyte apoptosis, both of which contribute to contractile 
dysfunction and cardiomyocyte loss. Because of the limited mass of PMMTM particle 
collected, more demanding exposure approaches were not possible. Also because of the 
limited particle mass, elemental analysis was not undertaken; thus conclusions between 
elements and their contribution to the reported observations were not drawn. Indeed, future 
studies should employ inhalation exposure and in-depth elemental analysis to couple effects 
with a specific toxicant. Nevertheless, investigations into the acute effects of PMMTM 
exposure are not without value, as they provide insight into the potential toxicological 
mechanisms elicited by PMMTM exposure.
Although the current study is aimed at the populations proximal to MTM sites, our findings 
could provide a broader impact on our understanding of cardiovascular toxicology. The data 
presented in this manuscript show for the first time that exposure to PMMTM induces cardiac 
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dysfunction concomitant with increased mitochondrial-associated apoptotic signaling and 
decreased mitochondrial function. Furthermore, our findings suggest that there is a spatial 
component to this dysfunction, as evidenced by differential effects to spatially distinct 
mitochondrial subpopulations.
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Cardiac apoptotic index following mountaintop removal mining particulate matter (PMMTM) 
exposure. Representative fluorescent images of cardiac tissue. A: negative control with 
exclusion of TdT enzyme. B: positive control with inclusion of DNase I. C: control with 
vehicle instillation. D: exposure with PMMTM instillation. DAPI-stained nuclei are indicated 
in blue, whereas terminal dUTP nick-end labeling (TUNEL)-positive nuclei are shown in 
green, and red indicates heavy chain cardiac myosin. Scale bar = 50 μm. E: apoptotic index 
was calculated as the percentage of total cardiomyocyte nuclei that were TUNEL-positive 
nuclei. Values are means ± SE; n = 3 for each group. F: relative cytosolic histone 
concentrations determined by ELISA on left ventricular tissue from control and PMMTM-
exposed animals. Values are means ± SE; n = 5 for each group. *P < 0.05 for control vs. 
exposed.
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Cardiac caspase activities and content following PMMTM exposure. Fluorometric analysis of 
enzymatic activities of caspase-8 (A), caspase-9 (B), and caspase-3 (C) from the cytosol of 
rat left ventricles exposed by instillation to either vehicle control or PMMTM. Data are 
expressed as arbitrary units (AU). Relative protein contents of activated caspases from 
cytosolic fractions from left ventricles of rats exposed by instillation to either vehicle control 
or PMMTM. Representative Western blots (top) and densitometric analyses (bottom) for total 
protein content of caspase-8 (D), caspase-9 (E), and caspase-3 (F). All Western blots are 
expressed per GAPDH levels. Values are means ± SE; n = 6 for each group. *P < 0.05 for 
control vs. exposed.
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Apoptosome constituent contents. Relative protein contents of apoptosome constituents 
from cytosol and isolated mitochondrial subpopulations from left ventricles of rats exposed 
by instillation to either vehicle control or PMMTM. Representative Western blots (top) and 
densitometric analyses (bottom) for total protein content of cytosolic apoptosis protease 
activating factor 1 (APAF1) (A), cytosolic cytochrome c (Cyto C) (B), cytochrome c in the 
subsarcolemmal mitochondria (SSM) (C), and cytochrome c in the interfibrillar 
mitochondria (IFM) (D). Cytosolic proteins (A and B) were expressed per GAPDH levels, 
whereas mitochondrial analyses (C and D) were expressed per COX IV levels. Values are 
means ± SE; n = 8 for each group. *P < 0.05 for control vs. exposed.
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Bcl-2-associated X protein (Bax) and B-cell lymphoma 2 (Bcl-2) protein contents. Relative 
protein contents of total cell markers of apoptosis from left ventricles of rats exposed by 
instillation to either vehicle control or PMMTM. Representative immunoblots (top) and 
densitometric analyses (bottom) for cytosolic Bax (A) and Bcl-2 (B). C: ratio of 
densitometric analysis of Bax to Bcl-2. Western blots are expressed per GAPDH levels. 
Immunoblots from coimmunoprecipitation with Bax suggesting the formation of hetero-or 
homodimers with Bcl-2 (D) or Bax (E). Ratio of densitometric analysis of Bax dimers with 
Bax to Bcl-2 (F). Values are means ± SE; n = 8 for each group, *P < 0.05 for control vs. 
exposed.
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Mitochondrial permeability transition pore (mPTP) opening propensity. mPTP opening 
propensity from left ventricles of rats exposed by instillation to either vehicle control or 
PMMTM. Spectrophotometric analysis of mPTP opening propensity using the exogenous 
oxidant tert-butyl hydroperoxide (t-BuOOH) to induce mitochondrial swelling. Time to 
Vmax was assessed over a 15-min time period. Representative absorbance plots for SSM (A) 
and IFM (C). Solid lines represent control, dashed lines represent exposed, and dotted lines 
represent the internal control, cyclosporine A (CsA) treatment. Vmax data graphed for SSM 
(B) and IFM (D). Values are means ± SE; n = 6 for each group. *P < 0.05 for control vs. 
exposed.
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mPTP components. Relative protein content assessed by Western blotting of putative 
members of the mPTP from left ventricles of rats exposed by instillation to either vehicle 
control or PMMTM. Representative Western blots (top) and densitometric analyses (bottom) 
for total voltage-dependent anion channel (VDAC) in SSM (A) and in IFM (B), adenine 
nucleotide translocase (ANT) in SSM (C) and IFM (D), and cyclophilin D (CypD) in SSM 
(E) and IFM (F). All Western blots are expressed per COX IV levels. Values are means ± 
SE; n = 8 for each group. *P < 0.05 for control vs. exposed.
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Mitochondrial morphological assessment. Relative size and internal complexity were 
analyzed using mitotracker deep red 633 and flow cytometry. A: analysis of cardiac SSM 
and IFM size (forward scatter, FSC) in control and exposed mitochondria subpopulations. B: 
analysis of cardiac SSM and IFM internal complexity (side scatter, SSC) in control and 
exposed mitochondrial subpopulations. Representative electron micrographs of left ventricle 
tissue from control (C) and PMMTM exposed (D) animals. Values for both FSC and SSC are 
expressed as AU ± SE; n = 8 for each group. *P < 0.05 for control vs. exposed.
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Mitochondrial respiratory capacity. Representative polarographic traces of oxygen 
consumption following addition of glutamate and malate to SSM (A) and IFM (C). Solid line 
traces represent mitochondria from control, and dashed line traces represent mitochondria 
from PMMTM-exposed animals. Summary analyses of state 3 and state 4 respiration rates 
from trace measurements of SSM (B) and IFM (D). Respiration rates are expressed in 
nmol·min−1·mg protein−1. Values are means ± SE; n = 6 for each group. *P < 0.05 for 
control vs. exposed animals.
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Table 1
M-mode echocardiographic measurements
Parameter Control Average ± SE Exposed Average ± SE
Heart weight, mg 743.00 ± 39.39 837.00 ± 51.00
Body weight, g 299.63 ± 8.94 288.5 ± 1.50
Heart weight:body weight 2.51 ± 0.18 2.90 ± 0.19
Heart rate, beats/min 416.60 ± 10.38 403.54 ± 10.05
Systolic diameter, mm 2.29 ± 0.09 2.71 ± 0.18*
Diastolic diameter, mm 5.62 ± 0.08 5.84 ± 0.18
Systolic volume, μl 18.66 ± 1.97 29.46 ± 5.08*
Diastolic volume, μl 155.39 ± 5.22 171.61 ± 12.12
Stroke volume, μl 136.73 ± 5.54 142.15 ± 8.84
Ejection fraction, % 87.88 ± 1.25 83.53 ± 1.98*
Fractional shortening, % 59.16 ± 1.76 53.89 ± 2.09*
Cardiac output, ml/min 57.15 ± 3.16 57.33 ± 3.79
Values are means ± SE; n = 10 for each group.
*
P < 0.05 for control vs. exposed animals.
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